Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study.
Marcus MaurerAna Maria Giménez-ArnauJonathan A BernsteinChia-Yu ChuInna DanilychevaMichihiro HideMichael MakrisMartin MetzSinisa SavicKarl SitzWeily SoongPetra StaubachGordon SussmanAvantika BarveAlis BurciuEva HuaReinhold JanochaThomas SeverinPublished in: Allergy (2021)
ClinicalTrials.gov Identifier: NCT02477332 and NCT02649218.
Keyphrases